Cannabis Sativa, Inc. (CBDS)
USD 0.11
(-2.74%)
USD 0.11
(-2.74%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 206.45 Thousand USD | 2.35% |
| 2022 | 201.72 Thousand USD | -80.3% |
| 2021 | 1.02 Million USD | 15.54% |
| 2020 | 886.22 Thousand USD | 29.87% |
| 2019 | 682.41 Thousand USD | -11.91% |
| 2018 | 774.69 Thousand USD | 73.22% |
| 2017 | 447.23 Thousand USD | 130.37% |
| 2016 | 194.13 Thousand USD | 747.59% |
| 2015 | 22.9 Thousand USD | 188.11% |
| 2014 | -25.99 Thousand USD | -1383.02% |
| 2013 | 2026.00 USD | -96.46% |
| 2012 | 57.29 Thousand USD | 79.19% |
| 2011 | 31.97 Thousand USD | -11.37% |
| 2010 | 36.07 Thousand USD | 619.29% |
| 2009 | -6947.00 USD | -860.86% |
| 2008 | -723.00 USD | -103.62% |
| 2007 | 20 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 541.26 Thousand USD | 66.76% |
| 2024 Q1 | 324.58 Thousand USD | 57.21% |
| 2023 Q3 | 230.76 Thousand USD | -28.56% |
| 2023 Q4 | 206.45 Thousand USD | -10.53% |
| 2023 Q1 | 298.17 Thousand USD | 47.81% |
| 2023 Q2 | 323.01 Thousand USD | 8.33% |
| 2023 FY | 206.45 Thousand USD | 2.35% |
| 2022 Q3 | 20.74 Thousand USD | 130.04% |
| 2022 Q4 | 201.72 Thousand USD | 872.39% |
| 2022 Q2 | -69.05 Thousand USD | -106.35% |
| 2022 FY | 201.72 Thousand USD | -80.3% |
| 2022 Q1 | 1.08 Million USD | 6.13% |
| 2021 Q3 | 933.84 Thousand USD | 6.2% |
| 2021 Q2 | 879.3 Thousand USD | -4.08% |
| 2021 Q4 | 1.02 Million USD | 9.65% |
| 2021 Q1 | 916.66 Thousand USD | 3.44% |
| 2021 FY | 1.02 Million USD | 15.54% |
| 2020 Q4 | 886.22 Thousand USD | 332.61% |
| 2020 Q3 | -380.98 Thousand USD | 4.4% |
| 2020 FY | 886.22 Thousand USD | 29.87% |
| 2020 Q2 | -398.52 Thousand USD | -23.0% |
| 2020 Q1 | -324.01 Thousand USD | -147.48% |
| 2019 FY | 682.41 Thousand USD | -11.91% |
| 2019 Q3 | 765.15 Thousand USD | -16.17% |
| 2019 Q4 | 682.41 Thousand USD | -10.81% |
| 2019 Q2 | 912.75 Thousand USD | 3.52% |
| 2019 Q1 | 881.71 Thousand USD | 13.81% |
| 2018 FY | 774.69 Thousand USD | 73.22% |
| 2018 Q1 | 717.23 Thousand USD | 61.49% |
| 2018 Q2 | 667.91 Thousand USD | -6.88% |
| 2018 Q3 | 703.87 Thousand USD | 5.38% |
| 2018 Q4 | 774.69 Thousand USD | 10.06% |
| 2017 Q3 | 139.74 Thousand USD | 198.78% |
| 2017 FY | 447.23 Thousand USD | 130.37% |
| 2017 Q4 | 444.14 Thousand USD | 217.82% |
| 2017 Q2 | -141.46 Thousand USD | 67.59% |
| 2017 Q1 | -436.49 Thousand USD | -324.84% |
| 2016 Q4 | 194.13 Thousand USD | -26.49% |
| 2016 Q3 | 264.1 Thousand USD | 95.11% |
| 2016 FY | 194.13 Thousand USD | 747.59% |
| 2016 Q2 | 135.36 Thousand USD | 57.03% |
| 2016 Q1 | 86.2 Thousand USD | 338.82% |
| 2015 Q3 | -21.88 Thousand USD | -102.83% |
| 2015 Q2 | 774 Thousand USD | -78.18% |
| 2015 Q1 | 3.54 Million USD | 13744.19% |
| 2015 FY | 22.9 Thousand USD | 188.11% |
| 2015 Q4 | 19.64 Thousand USD | 189.76% |
| 2014 Q3 | 3.36 Million USD | 919.45% |
| 2014 Q4 | -25.99 Thousand USD | -100.77% |
| 2014 Q1 | 236.42 Thousand USD | 11569.3% |
| 2014 FY | -25.99 Thousand USD | -1383.02% |
| 2014 Q2 | 330.48 Thousand USD | 39.79% |
| 2013 FY | 2026.00 USD | -96.46% |
| 2013 Q2 | 53.17 Thousand USD | 9.44% |
| 2013 Q4 | 2026.00 USD | -83.64% |
| 2013 Q1 | 48.59 Thousand USD | -15.19% |
| 2013 Q3 | 12.38 Thousand USD | -76.71% |
| 2012 Q3 | 40.91 Thousand USD | 45.78% |
| 2012 Q4 | 57.29 Thousand USD | 40.02% |
| 2012 Q1 | 23.21 Thousand USD | -27.38% |
| 2012 Q2 | 28.06 Thousand USD | 20.88% |
| 2012 FY | 57.29 Thousand USD | 79.19% |
| 2011 Q3 | 24.91 Thousand USD | 37.87% |
| 2011 Q4 | 31.97 Thousand USD | 28.33% |
| 2011 FY | 31.97 Thousand USD | -11.37% |
| 2011 Q2 | 18.07 Thousand USD | -22.03% |
| 2011 Q1 | 23.17 Thousand USD | -35.76% |
| 2010 Q1 | 14.55 Thousand USD | 309.54% |
| 2010 Q3 | 25.95 Thousand USD | 89.54% |
| 2010 FY | 36.07 Thousand USD | 619.29% |
| 2010 Q4 | 36.07 Thousand USD | 39.0% |
| 2010 Q2 | 13.69 Thousand USD | -5.94% |
| 2009 Q1 | - USD | 100.0% |
| 2009 Q4 | -6947.00 USD | -169.47% |
| 2009 Q3 | 10 Thousand USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | -6947.00 USD | -860.86% |
| 2008 Q4 | -8040.00 USD | 0.0% |
| 2008 FY | -723.00 USD | -103.62% |
| 2007 FY | 20 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Achiko AG | 2.48 Million USD | 91.705% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 3.95 Million USD | 94.775% |
| CompuMed, Inc. | -686.23 Thousand USD | 130.086% |
| CompuGroup Medical SE & Co. KGaA | 775.35 Million USD | 99.973% |
| Cogstate Limited | -29.45 Million USD | 100.701% |
| CareView Communications, Inc. | 19.88 Million USD | 98.962% |
| Craneware plc | 783 Thousand USD | 73.632% |
| Caduceus Software Systems Corp. | 2.38 Million USD | 91.355% |
| Certive Solutions Inc. | 5.68 Million USD | 96.367% |
| Drug Free Solution, Inc. | -12.5 Thousand USD | 1751.4% |
| DATATRAK International, Inc. | 103.82 Thousand USD | -98.85% |
| Strainsforpains, Inc. | 1.93 Million USD | 89.311% |
| Healixa Inc. | 6.5 Million USD | 96.826% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | -668.66 Thousand USD | 130.876% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 459.64 Thousand USD | 55.083% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5062.82 USD | -3977.925% |
| iCoreConnect Inc. | 6.66 Million USD | 96.9% |
| IQ-AI Limited | -176.63 Thousand USD | 216.887% |
| Cannabiz Mobile, Inc. | 494.04 Thousand USD | 58.211% |
| Mednow Inc. | 2.11 Million USD | 90.259% |
| Galileo Life Sciences, Inc. | 17.02 Thousand USD | -1112.747% |
| MediXall Group, Inc. | 2.81 Million USD | 92.672% |
| Mitesco, Inc. | 1.76 Million USD | 88.295% |
| MobileSmith, Inc. | 4.85 Million USD | 95.749% |
| NantHealth, Inc. | 265.64 Million USD | 99.922% |
| Net Medical Xpress Solutions, Inc. | 661 Thousand USD | 68.766% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 8.48 Million USD | 97.567% |
| Patient Access Solutions, Inc. | 910.34 Thousand USD | 77.321% |
| Pharma-Bio Serv, Inc. | -10.09 Million USD | 102.044% |
| PPJ Healthcare Enterprises, Inc. | 2.54 Million USD | 91.884% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | 75.931% |
| Renalytix Plc | 3.85 Million USD | 94.644% |
| Revium Recovery Inc. | -529 Thousand USD | 139.028% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | -414.83 Thousand USD | 149.769% |
| Vaso Corporation | -9.28 Million USD | 102.224% |
| Vynleads, Inc. | 513.29 Thousand USD | 59.778% |